Test Price
800 AED✅ Home Collection Available
NTRK1 Gene Rearrangement Assay (FISH) in UAE | 800 AED | 2026 DHA Guidelines
تحليل إعادة الترتيب الجيني NTRK1 (FISH) في الإمارات | 800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary | الملخص التنفيذي
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy.
Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation by DHA‑licensed oncologists.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
يضمن التشخيص الجزيئي بدقة عالية باستخدام تقنية FISH للكشف عن إعادة ترتيب جين NTRK1 في الأنسجة السرطانية، مع جمع منزلي مبرد وخدمة استشارة هاتفية، امتثالاً للقانون الاتحادي رقم 41 لسنة 2024.
Comprehensive Test Overview
The NTRK1 Gene Rearrangement Assay (FISH) detects specific genomic rearrangements of the neurotrophic tyrosine receptor kinase 1 gene in solid tumors, directly guiding eligibility for targeted TRK inhibitor therapy. This 800 AED test uses fluorescence in‑situ hybridization on FFPE tissue blocks, delivering DHA‑licensed results within 4 working days.
| Feature | Our NTRK1 FISH Test | Closest Alternative (NGS Panel) |
|---|---|---|
| Methodology | Fluorescence In‑Situ Hybridization (FDA‑cleared probes) | Next‑Generation Sequencing (RNA or DNA) |
| Diagnostic Sensitivity | >99% for known partner fusions | ~98% (requires high tumour content) |
| Turnaround Time | 4 working days | 7–10 working days |
| Cost | 800 AED | 2,500–3,500 AED |
| Sample Requirement | FFPE block or 3 sections on coated slides | FFPE block (10–15 slides) or fresh tissue |
| Regulatory Clearance | DHA‑licensed, ISO 9001:2015 | Variable; may lack local accreditation |
Physician Insight & Safety Protocol
“As a DHA‑licensed oncologist, I emphasize that a positive NTRK1 fusion result must be correlated with histopathology and clinical presentation before initiating TRK inhibitor therapy. This test is critical for identifying candidates for targeted treatment but should never be used as a standalone diagnostic tool. Always discuss results with your treating oncologist to ensure a comprehensive care plan.”
— Dr. Prabhakar Reddy, DHA License 61713011
Medication Warning
Do not discontinue any prescribed medication without consulting your doctor. Test results must be interpreted alongside your current treatment regimen.
Patient Safety Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Liquid cytology specimens (e.g., fine‑needle aspirates) are not acceptable; the assay requires adequate tumour tissue in a paraffin block. Patients who have recently completed chemotherapy should wait at least 2 weeks before biopsy to allow tissue recovery.
- Emergency Red Flags: If you experience sudden tumour site pain, active bleeding, or signs of infection (fever, redness) at the biopsy area, seek immediate medical attention.
For emergency assistance, contact your nearest DHA‑accredited hospital.
Patient FAQ & Clinical Guidance
What is the NTRK1 Gene Rearrangement Assay?
Snippet: The NTRK1 Gene Rearrangement Assay (FISH) detects specific DNA rearrangements in the NTRK1 gene within cancer cells, determining eligibility for targeted TRK inhibitor therapy.
This FISH‑based test visualizes gene fusions directly in tumour tissue, providing a fast and accurate yes/no answer regarding NTRK1 alteration status.
يقوم اختبار إعادة الترتيب الجيني NTRK1 بتحديد إعادة ترتيب الحمض النووي في جين NTRK1 في الخلايا السرطانية لتحديد الأهلية لعلاج TRK الموجه.
How should I prepare for the NTRK1 FISH test?
Snippet: No special preparation is required beyond providing a formalin‑fixed paraffin‑embedded tissue block or slides and the mandatory Genomics Clinical Information Requisition Form (Form 20).
Your surgeon or oncologist will arrange tissue submission; ensure the Form 20 is completed with all clinical details to avoid processing delays.
لا حاجة لتحضيرات خاصة قبل الاختبار، فقط يتم تقديم كتلة نسيج محفوظة بالفورمالين والبارافين أو شرائح مع استمارة المعلومات السريرية الجينومية المطلوبة.
What do the results mean for my cancer treatment?
Snippet: A positive result indicates an NTRK1 gene rearrangement, which may qualify you for targeted TRK inhibitor therapy, while a negative result suggests standard treatment.
All results are interpreted by a DHA‑licensed surgical pathologist and oncologist to integrate findings into your personalized care plan.
نتيجة إيجابية تشير إلى وجود إعادة ترتيب جين NTRK1 وقد تؤهلك لعلاج مثبطات TRK، بينما توجّه النتيجة السلبية نحو العلاجات القياسية.
UAE Regulatory Compliance
This adheres to Federal Decree‑Law No. 41 of 2024 (Art. 87) on health genomic data, UAE PDPL (Federal Decree‑Law No. 45), and follows CDS 2026 consent protocols for minors. Facility licensed (DHA: 9834453) and ISO 9001:2015 certified (INT/EGQ/2509DA/3139). All genomic information is processed with strict data confidentiality and patient privacy.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians